Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2485-2489

  Ma, Jun Qi ^a   Kurban, Shajidai ^a   Zhao, Jun Da ^a   Li, Qiao Zhi ^a   Hasimu, Ayshamgul ^a  

^a Medical University of Xinjiang   (China)

Author keywords

Cervical squamous cell carcinoma; DNA methylation; Riboflavin transporter gene

Indexed keywords

CARRIER PROTEIN; SLC52A3 PROTEIN, HUMAN;

ADULT; AGED; CANCER STAGING; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVIX UTERI; CHINA; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84899881893     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2485     Document Type: Article

References (19)

1. Binh H, Yang, Freddie I, et al (2004). cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer, 109, 418-24.
2. Brock KE, Berry G, Mock PA, et al (1988). Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst, 80, 580-5.
3. De Souza ACS, Kodach L, Gadelha FR, et al (2006). A promising action of riboflavin as a mediator of leukaemia cell death. Apoptosis, 11, 1761-71.
4. Fujimura M, Yamamoto S, Murata T, et al (2010). Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption. J Nutr, 140, 1722-7.
5. Hernandez BY, McDuffie K, Wilkens LR, et al (2003). Diet and premalignant lesions of the cervix: evidence of a protective role of folate, riboflavin, thiamine and vitamin B12. Cancer Causes Control, 14, 859-70.
6. IARC (1995). Monograph on Cancer, Human Papillomavirus. World Health Organization.
7. Ingrid C, Cristina B, Eleonora M, et al (2011). Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues. BMC Cancer, 11, 244.
8. Julaiti Ainiwaer, Abuduaini Tuerhong, Ayshamgul Hasim, et al. (2012). Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients. Mol Biol Rep, 40, 3769-75.
9. Kim YI (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers, 13, 511-9.
10. Lalai Suzuk, Yu-Hua Peng, Fu-sheng Zhou (2006). Analysis of the cervical cancer distribution in Xinjiang. J Xinjiang Medical University, 29, 569-71.
11. Maynur Eli, De-Sheng Li, Wei-Wei Zhang, et al (2012). Decreased blood riboflavin levels are correlated with defective expression of the riboflavin transporter 2 gene in gastric cancer. World J Gastroenterol, 18, 3112-8.
12. Murphy SJ, Anderson LA, Ferguson HR, et al (2010). Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus. J Nutr, 140, 1757-63.
13. Pangrekar J, Krishnaswamy K, Jagadeesan V (1993). Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem Toxicol, 31, 745-50.
14. Powers HJ (2003). Riboflavin (vitamin B-2) and health. Am J Clin Nutr, 77, 1352-60.
15. Powers HJ (2005). Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr, 135, 2960-6.
16. Sugiura T, Kato Y, Kubo Y, Tsuji A (2011). Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2. Drug Metab Pharmacokinet, 21, 375-83.
17. Taira K (2006). Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature, 441, 1176.
18. Yonezawa A, Masuda S, Katsura T, et al (2008). Identification and functional characterization of a novel human and rat ribo¬flavin transporter, RFT1. Am J Physiol Cell Physiol, 295, 632-41.
19. Zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50.